بدائل البحث:
fold decrease » fold increase (توسيع البحث), fold increased (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), teer decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
e fold » _ fold (توسيع البحث), 5 fold (توسيع البحث), 2 fold (توسيع البحث)
fold decrease » fold increase (توسيع البحث), fold increased (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), teer decrease (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
e fold » _ fold (توسيع البحث), 5 fold (توسيع البحث), 2 fold (توسيع البحث)
-
1201
PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues.
منشور في 2013"…One unit means a decrease in OD<sub>620</sub> per second. …"
-
1202
-
1203
The expression of genes related to mitochondria was decreased in Pgam2 mice.
منشور في 2013"…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …"
-
1204
-
1205
-
1206
-
1207
-
1208
-
1209
-
1210
-
1211
-
1212
Acute JMV2959 treatment decreases alcohol preference in rats.
منشور في 2013"…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …"
-
1213
-
1214
Acute JMV2959 treatment decreases alcohol intake in rats.
منشور في 2013"…<p>(A) The acute effects of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) administration on alcohol intake was evaluated at 1 hour time interval after both two and five months of voluntary alcohol consumption. …"
-
1215
-
1216
-
1217
-
1218
-
1219
PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis
منشور في 2016"…<p><b><i>Background:</i></b> Persistent hyperkalemia (serum potassium (K) ≥5.5 mEq/l) is a common condition in hemodialysis (HD) patients, is associated with increased mortality, and treatment options are limited. …"
-
1220